#immunotherapy

What is Immunotherapy?

06/06/23 - The Beginning of the End

Are We Closing in on a Cancer Cure?

Biomarkers and the Utility of Proteomics for Dose Optimization and Confirmation of Target Engagement

Immunotherapy in Treatment of Melanoma

Side Effects of Immunotherapy in Melanoma

Immunotherapy for Oligometastatic Disease

Immunotherapy for Patients with Driver Mutation

Immunotherapy Before Surgery in NSCLC

Students learn Animal Compassion-Lisbet Chirboga! Advanced Melanoma Treatment Options-Dr. Jason Luke & Kyleigh LiPira!

Mesothelioma Updates, Episode 4: Chemo and Immunotherapy

National Cancer Institute Researcher -- Exciting Finding in Fight Against Breast Cancer (And Potentially Others)

John Crissy 020322

Dietary Fiber abd Melanoma

Melanoma Updates Potential Toxicities Associated with Immunotherapy in the Treatment of Melanoma

A Promising Treatment Option for Patients Diagnosed with Head-and-neck Cancer

Can We Eat to STARVE Cancer? The NEW Science In the Defense Against Disease | Dr. William Li

Can We Eat to STARVE Cancer? The NEW Science In the Defense Against Disease | Dr. William Li

CReATe Author Series: Ep. 1 - Dr. Benjamin Murdock and Immune Mechanisms in ALS

Metastatic Triple Negative Breast Cancer Immunotherapy Treatment Options and Potential Side Effects

Episode 27 - Nobel Prize based NFT

Buzzfest After Parties, Pregnant at the Grammy's, Immunotherapy and More

Covid 19 Vaccintion in Cancer Patients

Pascal Touchon: A Mission to Transform the Lives of Patients with Serious Medical Conditions

Dr. Rosalyn Juergens: What Novel Therapies Are You Most Optimistic About as Potential Lung Cancer Treatments in the Next Few Years?

Dr. David Spigel: What are the most promising targeted therapy approaches in lung cancer for the next few years?

Dr. Pal on the Role of Interleukin-2 (IL-2) in Advanced Kidney Cancer Today

Dr. Monty Pal on Leading Options for First Line Treatment of Advanced Kidney Cancer

Dr. Heather Wakelee on the Most Promising New Agents and Pathways for Treating Lung Cancer in the Coming Years

Dr. Greg Riely on the Most Promising Upcoming New Targeted Agents and Molecular Pathways for Lung Cancer Treatment

Dr. Geoffrey Oxnard on the Most Promising Upcoming New Targeted Agents and Molecular Pathways for Lung Cancer Treatment

Dr. Phil Bonomi on the Most Promising Upcoming New Targeted Agents and Molecular Pathways for Lung Cancer Treatment

Drs. Ross Camidge and Corey Langer: Which New Targets and Therapies Could We Bring to the Lung Cancer Clinic in the Near Future?

Dr. Karen Kelly on the Most Promising Upcoming New Targeted Agents and Molecular Pathways for Lung Cancer Treatment

Dr. Bob Doebele on the Most Promising Upcoming New Targeted Agents and Molecular Pathways for Lung Cancer Treatment

Squamous Lung Cancer Part 5, Q and A Session (video)

ASCO Lung Cancer Highlights, Part 3: Immunotherapy for Stage III NSCLC (audio)

Squamous Lung Cancer, Part 4: Immunotherapy (audio)

How Do the Different Immune Checkpoint Inhibitors in Lung Cancer Compare?

Squamous Lung Cancer, Part 4: Immunotherapy (video)

ASCO Lung Cancer Highlights, Part 3: Immunotherapy for Stage III NSCLC (video)

Squamous Lung Cancer Part 5, Q and A Session (audio)

Can Vaccines Fight Lung Cancer?

In What Clinical Setting Should Immunotherapies Be Developed?

MK-3475 and its Efficacy in Lung Cancer

Teaching the Immune System to Attack Lung Cancer Tumors

What is PD1 and PDL1 in Kidney Cancer?

The Promise of Immunotherapy in Lung Cancer

The Promise of PD1 Inhibitors in Kidney Cancer

What is Immunotherapy and its Mechanisms of Action? Part 2